These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The "cryptic" mechanism of action of glucagon-like peptide-2. Rowland KJ; Brubaker PL Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G1-8. PubMed ID: 21527727 [TBL] [Abstract][Full Text] [Related]
3. Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine. Anini Y; Izzo A; Oudit GY; Backx PH; Brubaker PL Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1599-606. PubMed ID: 17284578 [TBL] [Abstract][Full Text] [Related]
4. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts. Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582 [TBL] [Abstract][Full Text] [Related]
5. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion. Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122 [TBL] [Abstract][Full Text] [Related]
6. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Sigalet DL; Wallace LE; Holst JJ; Martin GR; Kaji T; Tanaka H; Sharkey KA Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G211-21. PubMed ID: 17395898 [TBL] [Abstract][Full Text] [Related]
7. Life in the crypt: a role for glucagon-like peptide-2? Rowland KJ; Brubaker PL Mol Cell Endocrinol; 2008 Jun; 288(1-2):63-70. PubMed ID: 18403107 [TBL] [Abstract][Full Text] [Related]
8. ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut. Yusta B; Holland D; Koehler JA; Maziarz M; Estall JL; Higgins R; Drucker DJ Gastroenterology; 2009 Sep; 137(3):986-96. PubMed ID: 19523469 [TBL] [Abstract][Full Text] [Related]
10. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Dubé PE; Forse CL; Bahrami J; Brubaker PL Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611 [TBL] [Abstract][Full Text] [Related]
11. [Glucagon-like peptides--synthesis, biological actions and some clinical implications]. Otto Buczkowska E; Dworzecki T Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906 [TBL] [Abstract][Full Text] [Related]
12. Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine. McDonagh SC; Lee J; Izzo A; Brubaker PL Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G461-8. PubMed ID: 17585017 [TBL] [Abstract][Full Text] [Related]
13. [Transfection and identification of the cloned strain that stably expressing glucagon like peptide-2 receptor in CaCO2 cell lines]. Zhao Y; Wang FJ; Wang P; Qi HB; Wang SL Zhonghua Shao Shang Za Zhi; 2006 Aug; 22(4):258-61. PubMed ID: 17175639 [TBL] [Abstract][Full Text] [Related]
14. GLP-2 receptor expression in excitatory and inhibitory enteric neurons and its role in mouse duodenum contractility. Cinci L; Faussone-Pellegrini MS; Rotondo A; Mulè F; Vannucchi MG Neurogastroenterol Motil; 2011 Sep; 23(9):e383-92. PubMed ID: 21752156 [TBL] [Abstract][Full Text] [Related]